Medicare Enrolled
Dr. Matthew Riebel, M.D.
Urology Physician · Worthington, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Riebel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Riebel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Riebel
Dr. Matthew Riebel is an urology physician in Worthington, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Riebel performed 3,391 Medicare services across 1,178 unique beneficiaries.
Between the years covered by Open Payments, Dr. Riebel received a total of $2,588 from 32 pharmaceutical and/or device companies across 123 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Riebel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 15% volume in OH
$2,588 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,391
Medicare services
Top 15% in OH for urology physician
1,178
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~178 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,600 | $0 | $2 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
405 | $45 | $181 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
261 | $54 | $186 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
152 | $8 | $31 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
138 | $40 | $145 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
132 | $84 | $268 |
| PSA test (prostate cancer screening) | 107 | $18 | $68 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
105 | $47 | $184 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
62 | $36 | $140 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
38 | $8 | $129 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
35 | $173 | $548 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $101 | $386 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
33 | $36 | $139 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
29 | $91 | $454 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
25 | $3 | $8 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
22 | $330 | $1,498 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
18 | $2 | $9 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $57 | $278 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
17 | $557 | $4,753 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
17 | $14 | $77 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
17 | $22 | $96 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
17 | $129 | $1,573 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
16 | $63 | $508 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
16 | $174 | $1,154 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
14 | $50 | $263 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
13 | $464 | $3,407 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
13 | $125 | $682 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $100 | $298 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
12 | $239 | $679 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
12 | $45 | $239 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
51.5% medium
47.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,588
Total received (2018-2024)
Avg $370/year across 7 years
Top 48% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
123
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,588 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$590
2023
$663
2022
$439
2021
$218
2020
$118
2019
$219
2018
$342
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dendreon Pharmaceuticals LLC
$201
Medtronic, Inc.
$90
PFIZER INC.
$64
Astellas Pharma US Inc
$42
Sumitomo Pharma America, Inc.
$35
ABBVIE INC.
$33
ConvaTec Inc.
$22
Endo Pharmaceuticals Inc.
$20
IMMUNITYBIO, INC.
$18
VERTEX PHARMACEUTICALS INCORPORATED
$18
PROGENICS PHARMACEUTICALS, INC.
$17
Teleflex LLC
$15
ACCORD HEALTHCARE, INC.
$15
Top 3 companies account for 60.3% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$625
Dendreon Pharmaceuticals LLC
$286
Medtronic, Inc.
$238
PFIZER INC.
$212
UroGen Pharma, Inc.
$198
Janssen Biotech, Inc.
$135
Sumitomo Pharma America, Inc.
$100
UROVANT SCIENCES INC
$100
Endo Pharmaceuticals Inc.
$74
ABBVIE INC.
$57
Myovant Sciences Inc.
$54
TOLMAR Pharmaceuticals, Inc.
$53
Amgen Inc.
$49
Bayer Healthcare Pharmaceuticals Inc.
$47
Progenics Pharmaceuticals, Inc.
$37
PROCEPT BioRobotics Corporation
$29
Antares Pharma, Inc.
$28
GENZYME CORPORATION
$28
ConvaTec Inc.
$22
BOSTON SCIENTIFIC CORPORATION
$22
AstraZeneca Pharmaceuticals LP
$20
IMMUNITYBIO, INC.
$18
VERTEX PHARMACEUTICALS INCORPORATED
$18
C. R. Bard, Inc. & Subsidiaries
$18
Boston Scientific Corporation
$18
PROGENICS PHARMACEUTICALS, INC.
$17
MEDIVATION FIELD SOLUTIONS LLC
$15
Teleflex LLC
$15
ACCORD HEALTHCARE, INC.
$15
UROGEN PHARMA, INC.
$15
Olympus America Inc.
$14
KARL STORZ Endoscopy-America
$13
Top 3 companies account for 44.4% of all-time payments
Associated products mentioned in payments ›
AMS 700 CXR RTE KIT · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · BOTOX · CAMCEVI · ELIGARD · ERLEADA · Erleada · FLEXIBLE VIDEO URETHRO-CYSTOSCOPE · GEMTESA · GENTLECATH GLIDE · INTERSTIM · JELMYTO · JEVTANA · LYNPARZA · MYRBETRIQ · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · Otrexup · PROVENGE · PYLARIFY · Prolia · Rezum Generator · TOVIAZ · UROLIFT · XIAFLEX · XTANDI · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
101
Per 100K population
7.6
County median income
$73,795
Nearest hospital
SUN BEHAVIORAL COLUMBUS
2.1 mi
2.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Riebel is a clinical cardiology specialist, with above-average Medicare volume (top 15% in OH), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Riebel experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Riebel performed 1,600 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Riebel receive payments from pharmaceutical companies?
Yes. Dr. Riebel received a total of $2,588 from 32 companies across 123 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Riebel's costs compare to other urology physicians in Worthington?
Dr. Riebel's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Riebel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Worthington
Browse urology physicians in Worthington ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology